Expand the RRDR hotspot to improve GeneXpert results

Affiliations

Comment

B Mishra et al. Int J Tuberc Lung Dis. 2019.

. 2019 Sep 1;23(9):1043.

doi: 10.5588/ijtld.19.0103.

¹ Department of Microbiology* and Department of Pulmonary Medicine & Critical Care All India Institute of Medical Sciences, Bhubaneswar, India.

No abstract available

Comment in

Implementation of Xpert^® MTB/RIF: real challenges, real promise.
Dowdy DW. Dowdy DW. Int J Tuberc Lung Dis. 2019 Oct 1;23(10):1123. doi: 10.5588/ijtld.19.0120. Int J Tuberc Lung Dis. 2019. PMID: 31627779 Free PMC article. No abstract available.

Xpert at 8 years: where are we now, and what should we do next?
Dowdy DW. Dowdy DW. Int J Tuberc Lung Dis. 2019 Jan 1;23(1):3-4. doi: 10.5588/ijtld.18.0717. Int J Tuberc Lung Dis. 2019. PMID: 30674373 Free PMC article. No abstract available.
Treatment outcomes, diagnostic and therapeutic impact: Xpert vs. smear. A systematic review and meta-analysis.
Agizew T, Boyd R, Auld AF, Payton L, Pals SL, Lekone P, Chihota V, Finlay A. Agizew T, et al. Int J Tuberc Lung Dis. 2019 Jan 1;23(1):82-92. doi: 10.5588/ijtld.18.0203. Int J Tuberc Lung Dis. 2019. PMID: 30674379 Free PMC article.